Merck Pioneers New Efforts to See MS from the Inside Out

Merck, a leading science and technology company, joins the global multiple sclerosis (MS) community in recognition of World MS Day, an initiative created by the Multiple Sclerosis International Federation (MSIF) to raise awareness of the 2.3 million people worldwide living with this challenging disease. In support of this year’s World MS Day theme, #MyInvisibleMS, Merck is making MS visible through a variety of initiatives aimed at shining a light on the hidden symptoms of MS. These invisible symptoms, which include visual problems, fatigue, pain and emotional changesi, can vary between…

Read More

Katie Couric Joins Merck and Cancer Advocates to Support Patients and Caregivers Through the Expansion of Your Cancer Game Plan (YCGP)

Merck has announced a collaboration with journalist, author and longtime cancer advocate, Katie Couric, to launch “With Love, Me,” a new feature of Merck’s U.S. patient awareness campaign, Your Cancer Game Plan. Couric will join the program, which showcases a series of heartfelt letters on WithLoveMe.com written by caregivers and cancer survivors to their former selves touching upon what they wished they had known – or needed to hear – when they were first coping with a cancer diagnosis. “A cancer diagnosis can be life-shattering. Having lost both my husband…

Read More

World MS Day 2018: Call for Greater Curiosity to Drive Understanding of the Disease and Future Innovation

Merck, a leading science and technology company, today announced its support of World MS Day 2018 and MS International Federation (MSIF)’s #BringingUsCloser campaign through a new campaign, #MSInsideOut, to support the multiple sclerosis (MS) community and deepen understanding of the disease. The initiative will involve a collaboration with Shift.ms, the social network for people with MS, who will be Executive Producers on a new documentary which will feature unique perspectives from the MS community. The documentary will premiere at the 34th Congress of the European Committee for Treatment and Research…

Read More

Cancer Research UK and the Institute of Cancer Research, London, join forces with Merck in new drug discovery alliance

Cancer Research UK’s Commercial Partnerships Team and The Institute of Cancer Research, London, announced a multi-project collaboration and licensing deal with Merck, a leading science and technology company, to discover and develop new anticancer drugs. This multi-project deal follows previous single project drug discovery collaborations and a more recent target validation collaboration between Merck and Cancer Research UK’s Cancer Therapeutics Unit at The Institute of Cancer Research (ICR). The parties will collaborate on three independent research projects spanning target hit discovery to preclinical candidate nomination. This work will progress the discovery and development…

Read More

Impassioned Lung Cancer Survivors Join Your Cancer Game Plan Campaign

A vivacious working mother. A motivated college athlete. A career-minded dad and avid runner. An energetic father and professional soccer referee. They differ in age, gender, athleticism and careers, yet each was stunned by a lung cancer diagnosis. Today, the four lung cancer survivors take every opportunity to right misperceptions about it being only a “smoker’s disease” and use their voices to advocate for others who are impacted by the number one cancer killer worldwide. They’ve joined leading lung cancer advocacy groups, CancerCare and Merck, known as MSD outside the United States and Canada, to bring their voices to Your Cancer Game Plan, an awareness…

Read More